Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
6.84
+0.05 (0.74%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Vanda Pharmaceuticals Employees
Vanda Pharmaceuticals had 533 employees as of December 31, 2025. The number of employees increased by 165 or 44.84% compared to the previous year.
Employees
533
Change (1Y)
165
Growth (1Y)
44.84%
Revenue / Employee
$405,450
Profits / Employee
-$413,647
Market Cap
404.30M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Puma Biotechnology | 179 |
| Invivyd | 122 |
| Enanta Pharmaceuticals | 120 |
| Niagen Bioscience | 117 |
| Neumora Therapeutics | 96 |
| Century Therapeutics | 78 |
| Lineage Cell Therapeutics | 77 |
VNDA News
- 10 hours ago - Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in NEJM Evidence - PRNewsWire
- 6 days ago - Vanda Pharmaceuticals Appoints Dr. Charles Duncan to its Board of Directors - PRNewsWire
- 19 days ago - Vanda Pharmaceuticals Calls on FDA to Withdraw Proposal from FY 2027 Legislative Agenda That Would Extend Drug Review Timelines - PRNewsWire
- 20 days ago - Vanda Pharmaceuticals Announces Initiation of The Thetis Study, a Clinical Trial of NEREUS™ for the Prevention of Vomiting Induced by GLP-1 Receptor Agonists - PRNewsWire
- 5 weeks ago - Vanda Pharmaceuticals Calls for Stronger FDA Action to Accelerate Shift from Animal Testing to Human-Relevant Methods - PRNewsWire
- 6 weeks ago - Vanda Pharmaceuticals Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 2 months ago - Vanda Announces FDA Grants Landmark Hearing for HETLIOZ® in Jet Lag Disorder, the First Drug Approval Hearing in Over 40 Years - PRNewsWire
- 2 months ago - Vanda Pharmaceuticals Announces Participation in the 2026 Citizens Life Sciences Conference - PRNewsWire